Hims & Hers plots wellness-and-longevity pivot beyond weight-loss meds
TL;DR
Hims & Hers, the telehealth company built on selling GLP-1 weight-loss drugs online, plans a pivot into wellness and longevity, including potentially FDA-regulated peptides. The founder-CEO aims to source peptides in the U.S. and lean on its mass-marketing platform to push broader wellness products, signaling a transition from prescription-focused care toward a broader wellness business amid regulatory scrutiny.
Topics:businesshealth#health#health-care-industry#medical-technology#medication#weight-loss#wellness
Hims & Hers CEO is plotting new ways to upend traditional health care The Washington Post
Want the full story? Read the original reporting
Read on The Washington Post